ICBC CREDIT SUISSE ASSET MGT CO LTD SSE STAR BIOLOGY AND MEDICINE IDX ETF CN
No trades
Key stats
About ICBC CREDIT SUISSE ASSET MGT CO LTD SSE STAR BIOLOGY AND MEDICINE IDX ETF CN
Home page
Inception date
Aug 8, 2024
Structure
Open-Ended Fund
SSE Science and Technology Innovation Board Biomedical Index Yield - CNY - Benchmark TR Gross
Replication method
Physical
Dividend treatment
Distributes
Primary advisor
ICBC Credit Suisse Asset Management Co., Ltd.
ISIN
CNE100006G64
Classification
What's in the fund
Exposure type
Health Technology
Stock breakdown by region
Top 10 holdings
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related funds
Frequently Asked Questions
An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.
588860 trades at 1.410 CNY today, its price has fallen −0.63% in the past 24 hours. Track more dynamics on 588860 price chart.
588860 net asset value is 1.39 today — it's risen 9.30% over the past month. NAV represents the total value of the fund's assets less liabilities and serves as a gauge of the fund's performance.
588860 assets under management is 214.77 M CNY. AUM is an important metric as it reflects the fund's size and can serve as a gauge of how successful the fund is in attracting investors, which, in its turn, can influence decision-making.
588860 price has risen by 11.90% over the last month, and its yearly performance shows a 42.71% increase. See more dynamics on 588860 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 9.30% over the last month, showed a 13.89% increase in three-month performance and has increased by 26.02% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by 9.30% over the last month, showed a 13.89% increase in three-month performance and has increased by 26.02% in a year.
588860 fund flows account for −81.61 M CNY (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.
588860 invests in stocks. See more details in our Analysis section.
No, 588860 isn't leveraged, meaning it doesn't use borrowings or financial derivatives to magnify the performance of the underlying assets or index it follows.
In some ways, ETFs are safe investments, but in a broader sense, they're not safer than any other asset, so it's crucial to analyze a fund before investing. But if your research gives a vague answer, you can always refer to technical analysis.
Today, 588860 technical analysis shows the buy rating and its 1-week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating 588860 shows the strong buy signal. See more of 588860 technicals for a more comprehensive analysis.
Today, 588860 technical analysis shows the buy rating and its 1-week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating 588860 shows the strong buy signal. See more of 588860 technicals for a more comprehensive analysis.
No, 588860 doesn't pay dividends to its holders.
588860 trades at a premium (0.15%).
Premium/discount to NAV expresses the difference between the ETF’s price and its NAV value. A positive percentage indicates a premium, meaning the ETF trades at a higher price than the calculated NAV. Conversely, a negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.
Premium/discount to NAV expresses the difference between the ETF’s price and its NAV value. A positive percentage indicates a premium, meaning the ETF trades at a higher price than the calculated NAV. Conversely, a negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.
588860 shares are issued by ICBC Credit Suisse Asset Management Co., Ltd.
588860 follows the SSE Science and Technology Innovation Board Biomedical Index Yield - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
The fund started trading on Aug 8, 2024.
The fund's management style is passive, meaning it's aiming to replicate the performance of the underlying index by holding assets in the same proportions as the index. The goal is to match the index's returns.